InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Jeffrey Robert Ajer, EVP, Chief Commercial Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 16 open-market SEC Form 4 transactions: 0 purchases worth $0 and 16 sales worth $8.3M, reported from Sep 22, 21 to May 2, 24. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 2, 24 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 5.0K | $82.91 | $415K |
| Mar 5, 24 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 4.0K | $87.07 | $348K |
| Sep 18, 23 | NKTRNEKTAR THERAPEUTICS | SELL | 4.4K | $0.69 | $3K |
| Aug 16, 23 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 5.0K | $90.00 | $450K |
| Jan 25, 23 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 44.8K | $116.15 | $5.2M |
| Nov 2, 22 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 3.0K | $86.12 | $258K |
| Sep 23, 22 | NKTRNEKTAR THERAPEUTICS | SELL | 4.2K | $3.16 | $13K |
| Aug 11, 22 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 3.0K | $95.62 | $287K |
| May 26, 22 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 1.3K | $78.94 | $103K |
| Apr 13, 22 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 1.2K | $82.47 | $97K |
| Mar 30, 22 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 1.4K | $79.56 | $110K |
| Mar 29, 22 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 1.6K | $79.43 | $129K |
| Mar 23, 22 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 6.1K | $81.78 | $501K |
| Mar 22, 22 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 2.1K | $81.00 | $168K |
| Oct 26, 21 | BMRNBIOMARIN PHARMACEUTICAL INC | SELL | 2.7K | $73.60 | $202K |
| Sep 22, 21 | NKTRNEKTAR THERAPEUTICS | SELL | 3.7K | $17.78 | $65K |